BioElectronics Corporation Elects New Chairman

* Reuters is not responsible for the content in this press release.

Tue Jul 7, 2009 10:00am EDT

  FREDERICK, MD, Jul 07 (MARKET WIRE) -- 
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive,
disposable drug-free anti-inflammatory devices, today announced that its
board of directors has unanimously elected a new chairman, Dr. Richard
Staelin, a Duke University Professor and long-time BioElectronics board
member. Dr. Staelin is the Edward and Rose Donnell Professor of Business
Administration at The Fuqua School of Business, Duke University.

    "We are pleased at this critical inflection point in Bioelectronics'
business development that we are able to engage a leader with Dr.
Staelin's superb marketing and business acumen to lead our board of
directions," said Andrew J. Whelan, Bioelectronics' CEO. "Now that our
products are developed and approved by multiple health authorities around
the world, we are poised to drive growth in world-wide markets."

    Dr. Staelin has written more than 80 articles on a range of marketing and
technology issues including consumer protection regulation and its impact
on consumer behavior, channel management, marketing strategy and service
quality especially in hospitals.

    Much of Dr. Staelin's consulting activity has been for the Federal
Government (the FDA and the FTC), or as an expert witness in antitrust
cases concerned with disputes between manufacturers and dealers. Professor
Staelin also has worked with Adtel (a division of Burke Marketing),
developing new ways to measure the effects of advertising and couponing on
purchase behavior. He is also the current president of the INFORMS Society
of Marketing Scientists.

    "I believe BioElectronics has successfully established a beachhead in the
introduction of its new class of devices that not only relieve pain, but
also help heal the cells that are the root cause of this pain," Staelin
said. "These wearable PEMF devices provide localized pain relief without
drugs at a fraction of the cost of hospital-administered treatments."

    Staelin has been on the BioElectronics board for three years and has
served as the head of the Audit committee.

    About BioElectronics Corporation

    BioElectronics Corporation is the maker of ActiPatch(R) Therapy,
RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and
the Allay(TM) family of inexpensive, disposable drug-free
anti-inflammatory devices. For more information please see
http://www.BioElectronicsCorp.com.

    

For media enquiries, please contact:
Joe Noel
BioElectronics Corp.
(925) 922-2560

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.